Top Markets
#1 Helium Helium +51.09%
#2 TENDIES TENDIES +30.56%
#3 Pons Pons +15.36%
#4 Songbird Songbird +15.22%
#5 Biconomy Biconomy +12.67%
#6 MarsCoin MarsCoin +11.35%
#7 OSK OSK +9.78%
#8 pipedog pipedog +8.51%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +8.18%
#10 Audiera Audiera +6.96%
Coin of the day
Helium Helium
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Chongqing Lummy Pharmaceutical Co., Ltd. Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

300006
Rangering i aksjer #10090
Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the... Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.
Aksjekurs
$0.84484795
Sist synkronisert: 2026-08-28
Markedsverdi
$892.08M
Endring (1 dag)
-4.11%
Endring (1 år)
27.37%
Land
CN
Handel Chongqing Lummy Pharmaceutical Co., Ltd. (300006)

Kategori

Healthcare
Inntekter for Chongqing Lummy Pharmaceutical Co., Ltd. (300006)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Chongqing Lummy Pharmaceutical Co., Ltd. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Chongqing Lummy Pharmaceutical Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B -
US